Xin Nakanishi's most recent trade in Oncternal Therapeutics Inc was a trade of 25,000 Stock Options done . Disclosure was reported to the exchange on June 28, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oncternal Therapeutics Inc | Xin Nakanishi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
Oncternal Therapeutics Inc | Xin Nakanishi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,000 | 25,000 | - | - | Stock Options | |
Oncternal Therapeutics Inc | Xin Nakanishi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 25,000 | 25,000 | - | - | Stock Options | |
Oncternal Therapeutics Inc | Xin Nakanishi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 15,000 | 15,000 | - | - | Stock Option |